Advanced drug delivery and targeting technologies for the ocular diseases
نویسندگان
چکیده
منابع مشابه
Advanced drug delivery and targeting technologies for the ocular diseases
INTRODUCTION Ocular targeted therapy has enormously been advanced by implementation of new methods of drug delivery and targeting using implantable drug delivery systems (DDSs) or devices (DDDs), stimuli-responsive advanced biomaterials, multimodal nanomedicines, cell therapy modalities and medical bioMEMs. These technologies tackle several ocular diseases such as inflammation-based diseases (e...
متن کاملOcular Drug Delivery: Targeting the Posterior Segment
One inch or less. That is the short distance an ocular drug must travel to reach a target site at the back of the eye. Research has come a long way over the past 4 decades in efforts to make this inch-long journey more successful. Delivering ocular drugs to their target tissues often requires them to traverse the fat-water-fat structure of the corneal barrier while ensuring minimum wastage thro...
متن کاملOcular Drug Delivery: Targeting the Posterior Segment
An inch or less. That is the short distance an ocular drug must travel to reach a target site at the back of the eye. Research has traveled a long way over the past 4 decades in efforts to make this inch-long journey more successful. Delivering ocular drugs to their target tissues often requires them to traverse the fatwater-fat structure of the corneal barrier, while ensuring minimum wastage t...
متن کاملNanomedicine – The role of newer drug delivery technologies in cancer
Nanotechnology has slowly but steadily revolutionized the diagnosis, imaging and treatment of cancer. Detecting cancer at earliest stages, locating the tumor at different areas in the body and specific delivery of the drugs to malignant cells including surgically inaccessible tumors are the core areas of medical and pharmaceutical research across the world. In this endeavour, Nanodevices have e...
متن کاملSector Overview Ocular Drug Delivery Technologies : Exciting times Ahead
The 2010 global cost of vision loss was nearly US$3 trillion (£2 trillion) for the 733 million people living with low vision and blindness,1 with this number expected to increase significantly due to the aging population and the increasing incidence of metabolic disorders such as diabetes. This makes eye disorders one of the costliest health conditions worldwide. The major blinding disorders cu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BioImpacts
سال: 2016
ISSN: 2228-5660,2228-5652
DOI: 10.15171/bi.2016.07